Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza.

Madan, Anuradha; Chen, Shuguang; Yates, Phillip; Washburn, Michael L; Roberts, Grace; Peat, Andrew J; Tao, Yu; Parry, Michael F; Barnum, Otis; McClain, Micah T; Roy-Ghanta, Sumita

Madan, Anuradha; Chen, Shuguang; Yates, Phillip; Washburn, Michael L; Roberts, Grace; Peat, Andrew J; Tao, Yu; Parry, Michael F; Barnum, Otis; McClain, Micah T; Roy-Ghanta, Sumita.

Affiliation

Madan A; GlaxoSmithKline, Upper Providence, Pennsylvania.
Chen S; GlaxoSmithKline, Upper Providence, Pennsylvania.
Yates P; GlaxoSmithKline, Stevenage, United Kingdom.
Washburn ML; GlaxoSmithKline, Upper Providence, Pennsylvania.
Roberts G; GlaxoSmithKline, Research Triangle Park, North Carolina.
Peat AJ; GlaxoSmithKline, Upper Providence, Pennsylvania.
Tao Y; GlaxoSmithKline, Upper Providence, Pennsylvania.
Parry MF; Stamford Hospital, Stamford, Connecticut.
Barnum O; Natchitoches Regional Medical Center, Natchitoches, Louisiana.
McClain MT; Duke University Center for Applied Genomics and Precision Medicine, Durham, North Carolina.
Roy-Ghanta S; GlaxoSmithKline, Upper Providence, Pennsylvania.

Open Forum Infect Dis ; 6(4): ofz163, 2019 Apr.

Article in En | MEDLINE | ID: mdl-31041358

Key words

CXCR2 antagonist; danirixin; hospitalization; influenza; neutrophils

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Open Forum Infect Dis Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google